Cigna (NYSE:CI – Get Rating) will be posting its quarterly earnings results before the market opens on Friday, May 6th. Analysts expect Cigna to post earnings of $5.13 per share for the quarter. Cigna has set its FY22 guidance at at least $22.40 EPS.Individual interested in participating in the company’s earnings conference call can do so using this link.
Cigna (NYSE:CI – Get Rating) last posted its quarterly earnings data on Thursday, February 3rd. The health services provider reported $4.77 earnings per share for the quarter, beating the Zacks’ consensus estimate of $4.68 by $0.09. Cigna had a net margin of 3.08% and a return on equity of 14.59%. The business had revenue of $45.69 billion for the quarter, compared to analysts’ expectations of $43.98 billion. During the same quarter in the previous year, the business posted $3.51 earnings per share. The business’s revenue was up 9.5% compared to the same quarter last year. On average, analysts expect Cigna to post $23 EPS for the current fiscal year and $25 EPS for the next fiscal year.
CI stock opened at $254.24 on Friday. The stock has a market capitalization of $80.94 billion, a price-to-earnings ratio of 16.15, a price-to-earnings-growth ratio of 1.06 and a beta of 0.86. Cigna has a twelve month low of $191.74 and a twelve month high of $272.81. The company has a quick ratio of 0.70, a current ratio of 0.70 and a debt-to-equity ratio of 0.66. The firm’s fifty day simple moving average is $243.93 and its two-hundred day simple moving average is $228.80.
A number of analysts recently weighed in on the stock. Wells Fargo & Company raised shares of Cigna from an “equal weight” rating to an “overweight” rating and upped their price objective for the stock from $236.00 to $278.00 in a research note on Thursday, January 6th. Deutsche Bank Aktiengesellschaft lowered shares of Cigna from a “buy” rating to a “hold” rating and lowered their price objective for the stock from $271.00 to $236.00 in a research note on Friday, February 4th. Mizuho boosted their target price on shares of Cigna from $245.00 to $266.00 and gave the stock a “buy” rating in a report on Wednesday, March 2nd. Morgan Stanley reduced their target price on shares of Cigna from $238.00 to $235.00 and set an “equal weight” rating for the company in a report on Thursday, February 10th. Finally, StockNews.com assumed coverage on shares of Cigna in a report on Thursday, March 31st. They issued a “strong-buy” rating for the company. One equities research analyst has rated the stock with a sell rating, seven have issued a hold rating, fourteen have assigned a buy rating and two have assigned a strong buy rating to the company. According to MarketBeat, the stock presently has an average rating of “Buy” and a consensus target price of $261.35.
In related news, EVP Everett Neville sold 268 shares of the business’s stock in a transaction dated Monday, February 28th. The shares were sold at an average price of $228.70, for a total transaction of $61,291.60. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, CEO David Cordani sold 45,380 shares of the company’s stock in a transaction dated Wednesday, April 20th. The stock was sold at an average price of $268.10, for a total transaction of $12,166,378.00. Following the completion of the transaction, the chief executive officer now owns 152,750 shares of the company’s stock, valued at approximately $40,952,275. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 91,836 shares of company stock valued at $23,795,261. Company insiders own 0.80% of the company’s stock.
Several large investors have recently modified their holdings of the company. Zullo Investment Group Inc. acquired a new stake in Cigna during the fourth quarter valued at approximately $68,000. EverSource Wealth Advisors LLC acquired a new stake in shares of Cigna during the fourth quarter valued at approximately $106,000. Sequoia Financial Advisors LLC acquired a new stake in shares of Cigna during the fourth quarter valued at approximately $216,000. Cypress Capital Group acquired a new position in Cigna in the 4th quarter valued at approximately $237,000. Finally, NEXT Financial Group Inc increased its stake in Cigna by 108.3% in the 4th quarter. NEXT Financial Group Inc now owns 1,204 shares of the health services provider’s stock valued at $276,000 after buying an additional 626 shares during the period. 86.39% of the stock is owned by institutional investors.
Cigna Company Profile (Get Rating)
Cigna Corporation provides insurance and related products and services in the United States. Its Evernorth segment provides a range of coordinated and point solution health services, including pharmacy, benefits management, care delivery and management, and intelligence solutions to health plans, employers, government organizations, and health care providers.
- Get a free copy of the StockNews.com research report on Cigna (CI)
- There’s An Institutional Floor In Keurig Dr. Pepper
- Ford Falls Despite Optimistic Outlook
- Harley-Davidson Skids Into A Buying Opportunity
- Facebook (NASDAQ: FB) Soars And Wall Street Delights
- Automatic Data Processing Is Ready To Scale New Heights
Receive News & Ratings for Cigna Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna and related companies with MarketBeat.com's FREE daily email newsletter.